Connect with us


Parents, it’s time to make a COVID-19 vaccination appointment for your children



Experts weighed in on the brouhaha surrounding vaccinating children, advising parents not to wait until their children are 11 years old to get them vaccinated. This is particularly critical this year, as COVID-19 remains a health risk for students with schools reopening soon. Most vaccines require two doses, as well as a two-week waiting period to boost immunity. 

Since the outbreak, thousands of youngsters have been admitted to hospitals with COVID-19. Pfizer is the only company that offers Trusted Source to youngsters aged 12 to 17. It’s given in two doses, three weeks apart, and full immunity takes another two weeks.

Specialists recommend that non-vaccinated youngsters get immunised as soon as feasible. “Vaccines work,” says Dr Jeannie Kenkare, chief medical officer of PhysicianOne Urgent Care in Connecticut. “These are some of the most effective vaccines we’ve ever had in the case of COVID-19 immunizations,” she says.

The COVID-19 vaccine from Pfizer was licenced in May for children aged 12 to 16. The Food and Drug Administration (FDA) issued a warning regarding a probable link between the vaccine and myocarditis, or heart inflammation, in young patients. Because of the concerns, some parents have decided not to vaccinate their children. Pfizer claims to be working with the FDA to assure the vaccine’s safety.

According to the doctor, experts no longer expect COVID-19 will go away. “If parents wait too long to get their children vaccinated, the chances of the youngster contracting it increases”. Vaccinations aren’t required in public schools currently in most states, but that may change if more vaccine makers gain permission.

Experts say vaccines take time to take effect, and that time should not be after youngsters have begun mixing with other students at school. “The delta variety is far more contagious than other strains,” Kenkare explained. “Vaccination is now the greatest way of prevention.” Parents should ask their family doctor questions and share what they discover with other parents debating whether or not to have their children vaccinated.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


The right pricing will be crucial for the launch of Zydus Cadila’s vaccine.




The destiny of Zydus Cadila’s Covid vaccine is in doubt, as the vaccine’s price appears to be delaying its introduction into the vaccination program. The business has received emergency use authorization from the FDA to inject its Covid vaccine, ZyCoV-D, to children aged 12 to 18.

Zydus Cadila, located in Ahmedabad, has imported the pharmaJet, a needle-free applicator for painless intradermal vaccine delivery. 

Each jet is responsible for delivering a specific amount of vaccination. 

As a result, a single dose is split into two shots, one for each arm. “It’s an expensive device and hence jacks up the overall price,” a government official said.

Around 20,000 dosages can be administered with the jet injector.

The government has been purchasing Covaxin at 225 per dosage and Covishield, another Covid vaccine developed in India, at 215 per dose.

The price of the Zydus Cadila vaccine, according to Health Secretary Rajesh Bhushan, will be significantly more than that of existing vaccines.

Continue Reading


The next wave of healthcare innovation




Healthcare industry is currently one of the leaders in this race of startups. From Practo to Netmeds, India has seen companies go progress exponentially.  

Launched in March 2021, Know Your Prescription (KYP) is a patient-centric product that explains the prescription and addresses general, treatment-related queries in English, Hindi, Punjabi, Bengali, and Malayalam.   

 KYP assists in the understanding of medical prescriptions. All a patient has to do is visit the AI-enabled portal (QR code), which, after proper diligence, connects them to a WhatsApp number. They are paired with pharmacists or retired medical professionals in order to fully comprehend what their prescription entails. This reduces medication errors while also improving patient compliance and adherence.  

 The product is specially designed keeping the general population in mind, and the startup is eyeing a pan-India audience “with a major focus on Tier II and III cities”.

 The Delhi-based startup, with a team size of 12, has also signed a three-year contract with Centre for Sight, which is one of the largest chains in India with more than 47 centres.  

 It hopes to develop an app soon that will allow users to submit their questions, as well as onboard   qualified pharmacists and doctors to assist them.  

 As of now, KYP has over 5,000 unique paid clients. By Diwali, SiCureMi intends to implement a Rs 299   yearly membership scheme. Users will be able to upload prescriptions an unlimited number of   times as a result of this.

Continue Reading


The pandemic may take the sparkle out of India’s Diwali spending in 2021




Diwali, the Festival of Lights, is one of the most widely celebrated festivals in India. Every state has its puja and rituals to bring in this colorful festival.

Every year, people tend to spend a lot of money during this festive season. From crackers to sweets and dresses, a lot of money flows through businesses in the festive season. 

However, after the pandemic, things have changed and Diwali spending saw a huge downfall in 2020. 

Diwali spending not expected to recover in 2021

In 2019, Diwali was one of the fastest-growing business periods. Over 43% of Indians spent tons of money during this festive period. However, COVID-19 struck hard in 2020 leading India to enter into a pandemic season. With the whole country on lockdown and cases increasing, the big question was how would the festive period be treated in 2020.

To no surprise, Diwali 2020 reached a major low leading a lot of businesses to reach a loss. Only 17% claimed to have been eager to spend during the festival season in 2020. 

However, as Diwali 2021 approaches and COVID-19 has been accepted as the new normal, the question arises again, Will Diwali spending fully recover this year? The answer is there will be a small recovery and growth, but not a complete one. According to a survey carried out by YouGov, Diwali spending was calculated and it was shown that it rose by 10 points this year, with 91% of urban Indians saying they would be spending more this year.

While the festive season appears and everyone looks forward to celebrating, it is important to keep in mind that the pandemic is still around us and we need to ensure all safety measures are undertaken in this fight against COVID-19. 

Continue Reading